2025 Annual Meeting | C74 - Multiple Sclerosis Disease-modifying Treatment

Date Sunday 04/06/25

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Veronica K. Penyak Cipriani, MD

Topic(s) Multiple Sclerosis

CME Available 2.00 CME credits

Event Timeline
No timeline events available at this time.

Faculty Disclosures
Veronica K. Penyak Cipriani, MD	Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Penyak Cipriani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Pharmaceuticals. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Penyak Cipriani has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Penyak Cipriani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Penyak Cipriani has received research support from Genentech.